Quantcast

Latest Quest Diagnostics Stories

2014-09-12 12:24:52

MADISON, N.J., Sept. 12, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today celebrates a decade on the North America Dow Jones Sustainability Index (DJSI) and 11 consecutive years on the World DJSI. http://photos.prnewswire.com/prnvar/20130717/NY48934LOGO The Dow Jones Sustainability Index family ranks companies for corporate sustainability according to economic, environmental and social criteria. To be...

2014-09-08 16:25:41

Clinical testing volume and positivity rate both grew after the first case of the infectious disease spread to Western Hemisphere this year MADISON, N.J., Sept. 8, 2014 /PRNewswire/ -- A growing number of patients in the United States are being tested - and testing positive - for the mosquito-borne chikungunya virus, according to a study presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, D.C. The study, by scientists from Quest Diagnostics...

2014-08-27 12:30:09

Testing for the protein 14-3-3eta may improve the diagnosis of RA, including in early stages when treatment is most likely to improve outcomes MADISON, N.J., Aug. 27, 2014 /PRNewswire/ -- A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, according to a new study in The Journal of Rheumatology....

2014-07-23 16:28:04

MADISON, N.J., July 23, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Vicky Gregg to serve as a director, effective immediately, expanding the Board to 10 members. http://photos.prnewswire.com/prnvar/20140723/129949 Ms. Gregg served as the Chief Executive Officer of Chattanooga-based Blue Cross Blue Shield of Tennessee from 2003 through December 2012. Prior...

2014-07-16 12:27:42

Three-year analysis of more than 1.4 million test results also shows majority of Americans continue to put health at risk through dangerous drug combinations and skipping doses MADISON, N.J., July 16, 2014 /PRNewswire/ -- Five states that have implemented multi-faceted prescription drug abuse prevention programs in recent years showed the highest rate of decline in prescription drug misuse rates nationwide, according to a new study issued today by Quest Diagnostics (NYSE: DGX), the world's...

2014-07-07 16:24:05

MADISON, N.J., July 7, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2014 results on Thursday, July 24, 2014, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. http://photos.prnewswire.com/prnvar/20130717/NY48934LOGO The conference call can also be accessed in listen-only mode by...

2014-06-16 08:28:21

MADISON, N.J. and SAN DIEGO, June 16, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, and Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced an agreement under which Quest will offer national access to Sequenom Laboratories' MaterniT21(TM) PLUS laboratory-developed test (LDT). Using a maternal blood sample, the noninvasive prenatal test (NIPT)...

2014-06-10 12:30:10

MADISON, N.J., June 10, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today introduced a new cancer test service based on the FDA-approved THxID(®)-BRAF test from bioMerieux, a world leader in the field of in vitro diagnostics. The THxID(®)-BRAF test is a companion diagnostic for two treatments for melanoma. The test is intended to be used as an aid in selecting patients with melanoma whose tumors carry the BRAF...

2014-06-01 12:20:16

Diagnostic insights into gene mutations in solid tumor cancers will aid therapy selection and prognosis for patients and advance research NEW YORK and MADISON, N.J., June 1, 2014 /PRNewswire/ -- Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights into...

2014-05-21 16:26:57

MADISON, N.J., May 21, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share, payable on July 23, 2014 to shareholders of record of Quest Diagnostics common stock on July 9, 2014. http://photos.prnewswire.com/prnvar/20130717/NY48934LOGO About Quest DiagnosticsQuest Diagnostics is the world's leading provider of diagnostic...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related